SeaStar Medical Holding Corp
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 09/30/23 | FY 06/30/23 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.2M | $135,000 | $0 | — | — |
| Cost of revenue | $53,000 | $0 | $0 | — | — |
| Gross profit | $1.2M | $135,000 | $0 | — | — |
| Research and development | $7.5M | $9.1M | $6.0M | — | — |
| Operating expenses | $13.4M | $18.0M | $14.2M | — | — |
| Operating income | -$12.2M | -$17.8M | -$14.2M | — | — |
| Interest expense | $31,000 | $244,000 | $1.1M | — | — |
| Pretax income | -$12.1M | -$24.8M | -$26.2M | — | — |
| Income tax expense | $3,000 | $3,000 | $0 | — | — |
| Net income | -$12.2M | -$24.8M | -$26.2M | — | — |
| Balance Sheet | |||||
| Current assets | $13.6M | $3.8M | $2.3M | $1.2M | $1.2M |
| Total assets | $14.2M | $4.7M | $3.5M | $2.5M | $2.6M |
| Current liabilities | $3.7M | $6.8M | $13.0M | $12.8M | $14.4M |
| Total liabilities | $3.7M | $6.8M | $17.4M | $18.5M | $14.4M |
| Total debt | $525,000 | $574,000 | — | — | — |
| Stockholders' equity | $10.4M | -$2.2M | -$13.9M | -$16.0M | -$11.8M |
| Cash Flow Statement | |||||
| Cash from operations | -$13.6M | -$16.0M | -$10.3M | — | — |
| Stock-based compensation | $624,000 | $887,000 | $1.9M | — | — |
Shares outstanding 4.0M · Free float 89.1%
Annual filing data through FY ended December 31, 2025; float as of July 15, 2026.